Reverse transcriptase mutations in HIV-1-infected children treated with zidovudine. 1996

A Unal, and E Lorenzo, and M Brown, and L Smith, and S Matsuura, and G Scott, and W Scott
Department of Biochemistry and Molecular Biology, University of Miami School of Medicine, FL 33101, USA.

Human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) mutations were detected in DNA from peripheral blood mononuclear cells from 11 of 12 HIV-1-infected children after 11-20 months of zidovudine monotherapy. The number of children with mutations detected at each codon were as follows: codon 41, 4; codon 67, 2; codon 70, 7; codon 215, 7; codon 219, 0. Codon 41 mutations were found only in the presence of a codon 215 mutation and in the absence of a codon 70 mutation. The codon 41/215 mutant combination was associated with decline in weight-for-age z score during therapy, weight < 10th percentile, CD4+ cell counts < 3rd percentile, and immune-complex dissociated HIV-1 p24 antigen (ICD p24 Ag) levels > 100 pg/ml. Patients developing the codon 70 mutation tended to have body weight > 30th percentile, CD4+ cell counts > 25th percentile, and ICD p24 Ag < 100 pg/ml. The codon 41 mutation was associated with clinical deterioration during a 6-month followup period.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003062 Codon A set of three nucleotides in a protein coding sequence that specifies individual amino acids or a termination signal (CODON, TERMINATOR). Most codons are universal, but some organisms do not produce the transfer RNAs (RNA, TRANSFER) complementary to all codons. These codons are referred to as unassigned codons (CODONS, NONSENSE). Codon, Sense,Sense Codon,Codons,Codons, Sense,Sense Codons
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015215 Zidovudine A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by an azido group. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA during reverse transcription. It improves immunologic function, partially reverses the HIV-induced neurological dysfunction, and improves certain other clinical abnormalities associated with AIDS. Its principal toxic effect is dose-dependent suppression of bone marrow, resulting in anemia and leukopenia. AZT (Antiviral),Azidothymidine,3'-Azido-2',3'-Dideoxythymidine,3'-Azido-3'-deoxythymidine,AZT Antiviral,AZT, Antiviral,BW A509U,BWA-509U,Retrovir,3' Azido 2',3' Dideoxythymidine,3' Azido 3' deoxythymidine,Antiviral AZT,BWA 509U,BWA509U
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human

Related Publications

A Unal, and E Lorenzo, and M Brown, and L Smith, and S Matsuura, and G Scott, and W Scott
November 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association,
A Unal, and E Lorenzo, and M Brown, and L Smith, and S Matsuura, and G Scott, and W Scott
June 1994, AIDS research and human retroviruses,
A Unal, and E Lorenzo, and M Brown, and L Smith, and S Matsuura, and G Scott, and W Scott
May 2000, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,
A Unal, and E Lorenzo, and M Brown, and L Smith, and S Matsuura, and G Scott, and W Scott
March 2002, Antiviral therapy,
A Unal, and E Lorenzo, and M Brown, and L Smith, and S Matsuura, and G Scott, and W Scott
April 1997, Antiviral therapy,
A Unal, and E Lorenzo, and M Brown, and L Smith, and S Matsuura, and G Scott, and W Scott
January 2002, International journal of immunopathology and pharmacology,
A Unal, and E Lorenzo, and M Brown, and L Smith, and S Matsuura, and G Scott, and W Scott
December 1989, Science (New York, N.Y.),
A Unal, and E Lorenzo, and M Brown, and L Smith, and S Matsuura, and G Scott, and W Scott
January 1990, Disease markers,
A Unal, and E Lorenzo, and M Brown, and L Smith, and S Matsuura, and G Scott, and W Scott
April 2021, Genome,
A Unal, and E Lorenzo, and M Brown, and L Smith, and S Matsuura, and G Scott, and W Scott
December 2015, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!